"The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, today announced the clinical investigators and institutions that will lead four NIH HIV...
Read More
"A pre-exposure prophylaxis (PrEP) regimen containing an investigational long-acting form of the HIV drug cabotegravir injected once every eight weeks was safe and more effective than a daily oral...
Read More
"New NIAID-funded research answers longstanding questions about key steps in HIV replication. The scientists who conducted the research are the first to create an environment in a test tube where they...
Read More
"The National Institutes of Health has awarded approximately $10 million to support implementation science research to advance the goals of Ending the HIV Epidemic: A Plan for America, which aims...
Read More
"Initial data from a large NIH-supported clinical trial offer a detailed look at the health status of people aging with HIV around the world. With 7,770 participants enrolled in 12 countries across...
Read More
